Berenberg initiated coverage of Medacta Group with a Buy rating and CHF 150 price target. The firm’s channel checks with surgeons and industry executives have given it confidence that the business can continue to grow well ahead of the broader market in the medium term.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MEDGF: